A comparison of the β1 -selectivity of three β1 -selective β-blockers
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2710.2003.00477.x/fullpdf
Reference35 articles.
1. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party;Party;British Medical Journal,1985
2. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study;Olsson;American Journal of Hypertension,1991
3. Beta blockade after myocardial infarction: systematic review and meta regression analysis;Freemantle;British Medical Journal,1999
4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial;Committees;Lancet,1999
5. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF);Group;Lancet,1999
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The current position of β-blockers in hypertension: guidelines and clinical practice;Current Medical Research and Opinion;2024-04
2. β-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications;Current Medical Research and Opinion;2024-04
3. Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis;CASP J INTERN MED;2024
4. Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial – the AMCOR study;Current Medical Research and Opinion;2023-06-22
5. Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension;Journal of the Renin-Angiotensin-Aldosterone System;2023-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3